Skip to content
PulseMS
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studySystematic reviewPeer-reviewed

Human Study on Stereotactic Radiosurgery for Craniofacial Pain

This systematic review found that stereotactic radiosurgery (SRS) is an established treatment for trigeminal neuralgia associated with multiple sclerosis. However, its use for other conditions like glossopharyngeal neuralgia, trigeminal autonomic cephalalgias, and neuropathic facial pain is still investigational due to insufficient evidence.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

Understanding SRS's effectiveness for trigeminal neuralgia lays the groundwork for potential innovations in managing craniofacial pain disorders. However, the limited evidence for other pain types suggests caution.

What this does not prove

The review highlights the need for improved patient selection and more research to clearly define SRS's role in various craniofacial pain conditions, as current evidence is heterogeneous.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Systematic review
Participants / samples
Not reported
Randomised
Not reported
Controlled
Not reported
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
2026-09-18
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified

Original sources

Supporting passages (8)
study designThis review summarizes the current clinical indications, radiosurgical techniques, efficacy, safety, and limitations of SRS for medically refractory craniofacial pain disorders.
subjectsSRS is an established treatment for classical, idiopathic, and multiple sclerosis-related TN.
peer reviewedStereotactic radiosurgery for craniofacial pain disorders: current clinical applications and future perspectives.
findingsEXPERT OPINION: SRS is an established treatment for classical, idiopathic, and multiple sclerosis-related TN.
findingsAdvances in neuroimaging, radiosurgical technology, and treatment planning have expanded its application beyond trigeminal neuralgia (TN) to glossopharyngeal neuralgia (GN), trigeminal autonomic cephalalgias (TACs), and neuropathic facial pain (NFP).
limitationsFuture advances in neuroimaging, target localization, and understanding of craniofacial pain pathophysiology, together with well-designed studies, are expected to optimize patient selection and better define the role of SRS for those disorders.
limitationsIn contrast, its application to GN, tumor-related TN, TACs, and NFP remains investigational because of limited and heterogeneous evidence.
publication datePublication date: 2026-09-18

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.